Latest Health News

Page 4 of 271
McKesson delivered a strong fiscal second quarter, with revenue up 8% and adjusted diluted EPS rising 18%. The healthcare distributor lifted its full-year adjusted EPS guidance while expanding its specialty-care portfolio through new investments and acquisitions.
Ada Torres
Ada Torres
5 Nov 2026
Cencora delivered a stronger fiscal 2026, with adjusted earnings per share rising 12.3% and quarterly profit benefiting from the OneOncology acquisition. The healthcare distributor expects another 8% to 10% increase in adjusted EPS in fiscal 2027, while reshaping its reporting structure and lifting its dividend.
Ada Torres
Ada Torres
4 Nov 2026
CVS Health plans to separate its healthcare solutions and retail pharmacy businesses by the first half of 2028, while raising its 2026 earnings and cash-flow targets. The announcement came alongside stronger third-quarter results, though management flagged elevated cost trends and potential macroeconomic pressure.
Ada Torres
Ada Torres
4 Nov 2026
Scentre Group has reaffirmed its 2026 funds-from-operations and distribution targets after reporting stronger visitation, sales and leasing metrics across its Westfield portfolio. Exposure to David Jones remains material in floor space but limited in earnings terms, with rent paid through September.
Eva Park
Eva Park
4 Nov 2026
International Flavors & Fragrances raised the lower end of its 2026 sales and adjusted EBITDA guidance after broad-based third-quarter growth. The stronger operating result sits alongside a US$134 million pre-tax continuing-operations loss and a costly Food Ingredients separation still awaiting completion.
Victor Sage
Victor Sage
4 Nov 2026
Clorox delivered a sharp first-quarter rebound, helped by the GOJO acquisition and an easier comparison after last year’s ERP-related inventory drawdown. But rising commodity, manufacturing and logistics costs have pushed its full-year margin assumptions lower, with adjusted earnings now expected nearer the bottom of the unchanged range.
Victor Sage
Victor Sage
3 Nov 2026
Kimberly-Clark has completed its acquisition of Kenvue, leaving Kenvue shareholders with a mix of Kimberly-Clark stock and cash while ending Kenvue’s life as a standalone listed company. The transaction also transfers Kenvue’s debt and corporate obligations into a new wholly owned subsidiary.
Victor Sage
Victor Sage
3 Nov 2026
Kimberly-Clark has completed its acquisition of Kenvue, issuing about 281.1 million shares and taking on an integration programme expected to cost US$3.1 billion before tax. The combined group is targeting US$2.1 billion in annual run-rate synergies by reshaping its brands, segments and operating model.
Victor Sage
Victor Sage
3 Nov 2026
Latrobe Magnesium has lifted commissioning progress at its Victorian Phase 1B plant to 50%, with installation now 98% complete. The company continues to target first magnesium metal crowns exceeding 98% purity by the end of 2026, while remaining within its A$6.1 million project budget.
Victor Sage
Victor Sage
2 Nov 2026
Percheron Therapeutics has received a US FDA Safe to Proceed letter for Vanderbilt Health to begin an investigator-sponsored trial of HMBD-002 in combination with venetoclax and azacitidine. The early-stage study will target up to 20 patients with relapsed or refractory AML or AML with MDS.
Ada Torres
Ada Torres
2 Nov 2026
ResMed has delivered a stronger first quarter for fiscal 2027, with revenue up 6% to US$1.415 billion and net income rising 20% to US$418 million. The headline result was helped by a preliminary gain on the MatrixCare sale, while the core Sleep and Breathing Health business continued to expand.
Ada Torres
Ada Torres
2 Nov 2026
RBR Group has secured its first post-restart Mozambique LNG contract, but the A$2 million-scale award arrives alongside just A$32,000 in cash and overdue convertible notes. The company is relying on further contract wins, debt restructuring and new capital to bridge the gap.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive